![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 20
2022
Long, Junyu; Wang, Dongxu; Wang, Anqiang; Chen, Peipei; Lin, Yu; Bian, Jin; Yang, Xu; Zheng, Mingjun; Zhang, Haohai; Zheng, Yongchang; Sang, Xinting und Zhao, Haitao
(2022):
A mutation-based gene set predicts survival benefit after immunotherapy across multiple cancers and reveals the immune response landscape.
In: Genome Medicine, Bd. 14, Nr. 1, 20
Nie, Xin; Liu, Dawo; Zheng, Mingjun; Li, Xiao; Liu, Ouxuan; Guo, Qian; Zhu, Liancheng und Lin, Bei
(2022):
HERPUD1 promotes ovarian cancer cell survival by sustaining autophagy and inhibit apoptosis via PI3K/AKT/mTOR and p38 MAPK signaling pathways.
In: BMC Cancer, Bd. 22, Nr. 1, 1338
Gou, Rui; Zheng, Mingjun; Hu, Yuexin; Gao, Lingling; Wang, Shuang; Liu, Ouxuan; Li, Xiao; Zhu, Liancheng; Liu, Juanjuan und Lin, Bei
(2022):
Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer.
In: BMC Cancer, Bd. 22, Nr. 1, 690
Nie, Xin; Zheng, Mingjun; Gao, Lingling; Hu, Yuexin; Zhuang, Yuan; Li, Xiao; Zhu, Liancheng; Liu, Juanjuan und Lin, Bei
(2022):
Interaction between TMEFF1 and AHNAK proteins in ovarian cancer cells: Implications for clinical prognosis.
In: International Immunopharmacology, Bd. 107, 108726
2021
Topalov, Nicole Elisabeth; Mayr, Doris; Scherer, Clemens; Chelariu-Raicu, Anca; Beyer, Susanne; Hester, Anna; Kraus, Fabian; Zheng, Mingjun; Kaltofen, Till; Kolben, Thomas; Burges, Alexander; Mahner, Sven; Trillsch, Fabian; Jeschke, Udo und Czogalla, Bastian
(23. September 2021):
Actin Beta-Like 2 as a New Mediator of Proliferation and Migration in Epithelial Ovarian Cancer.
In: Frontiers in Oncology, Bd. 11, 713026
[PDF, 2MB]
Gou, Rui; Hu, Yuexin; Liu, Ouxuan; Dong, Hui; Gao, Lingling; Wang, Shuang; Zheng, Mingjun; Li, Xiao und Lin, Bei
(1. Juli 2021):
PGK1 Is a Key Target for Anti-Glycolytic Therapy of Ovarian Cancer: Based on the Comprehensive Analysis of Glycolysis-Related Genes.
In: Frontiers in Oncology, Bd. 11, 682461
[PDF, 5MB]
Long, Junyu; Wang, Dongxu; Yang, Xu; Wang, Anqiang; Lin, Yu; Zheng, Mingjun; Zhang, Haohai; Sang, Xinting; Wang, Hanping; Hu, Ke und Zhao, Haitao
(2021):
Identification of NOTCH4 mutation as a response biomarker for immune checkpoint inhibitor therapy.
In: Springer Nature Medicine, Bd. 19, Nr. 1, 154
Zheng, Mingjun; Long, Junyu; Chelariu-Raicu, Anca; Mullikin, Heather; Vilsmaier, Theresa; Vattai, Aurelia; Heidegger, Helene Hildegard; Batz, Falk; Keckstein, Simon; Jeschke, Udo; Trillsch, Fabian; Mahner, Sven und Kaltofen, Till
(2021):
Identification of a Novel Tumor Microenvironment Prognostic Signature for Advanced-Stage Serous Ovarian Cancer.
In: Cancers, Bd. 13, Nr. 13, 3343
Zheng, Mingjun; Hu, Yuexin; Gou, Rui; Li, Siting; Nie, Xin; Li, Xiao und Lin, Bei
(2021):
Development of a seven-gene tumor immune microenvironment prognostic signature for high-risk grade III endometrial cancer.
In: Molecular Therapy-Oncolytics, Bd. 22: S. 294-306
Vogelsang, Tilman L. R.; Vattai, Aurelia; Schmoeckel, Elisa; Kaltofen, Till; Chelariu-Raicu, Anca; Zheng, Mingjun; Mahner, Sven; Mayr, Doris; Jeschke, Udo und Trillsch, Fabian
(2021):
Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer.
In: International Journal of Molecular Sciences, Bd. 22, Nr. 16, 8479
Nie, Xin; Gao, Lingling; Zheng, Mingjun; Wang, Caixia; Wang, Shuang; Li, Xiao; Qi, Yue; Zhu, Liancheng; Liu, Juanjuan und Lin, Bei
(2021):
Overexpression of TMEFF1 in Endometrial Carcinoma and the Mechanism Underlying its Promotion of Malignant Behavior in Cancer Cells.
In: Journal of Cancer, Bd. 12, Nr. 19: S. 5772-5788
Hu, Yuexin; Zheng, Mingjun; Zhang, Dandan; Gou, Rui; Liu, Ouxuan; Wang, Shuang und Lin, Bei
(2021):
Identification of the prognostic value of a 2-gene signature of the WNT gene family in UCEC using bioinformatics and real-world data.
In: Cancer Cell International, Bd. 21, Nr. 1, 516
Hu, Yuexin; Zheng, Mingjun; Wang, Shuang; Gao, Lingling; Gou, Rui; Liu, Ouxuan; Dong, Hui; Li, Xiao und Lin, Bei
(2021):
Identification of a five-gene signature of the RGS gene family with prognostic value in ovarian cancer.
In: Genomics, Bd. 113, Nr. 4: S. 2134-2144
2020
Hu, Yuexin; Zheng, Mingjun; Wang, Caixia; Wang, Shuang; Gou, Rui; Liu, Ouxuan; Li, Xiao; Liu, Juanjuan und Lin, Bei
(2020):
Identification of KIF23 as a prognostic signature for ovarian cancer based on large-scale sampling and clinical validation.
In: American Journal of Translational Research, Bd. 12, Nr. 9: S. 4955-4976
Zheng, Mingjun; Mullikin, Heather; Hester, Anna; Czogalla, Bastian; Heidegger, Helene; Vilsmaier, Theresa; Vattai, Aurelia; Chelariu-Raicu, Anca; Jeschke, Udo; Trillsch, Fabian; Mahner, Sven und Kaltofen, Till
(2020):
Development and Validation of a Novel 11-Gene Prognostic Model for Serous Ovarian Carcinomas Based on Lipid Metabolism Expression Profile.
In: International Journal of Molecular Sciences, Bd. 21, Nr. 23, 9169
Kong, Lingming; Liu, Peng; Zheng, Mingjun; Xue, Busheng; Liang, Keke und Tan, Xiaodong
(2020):
Multi-omics analysis based on integrated genomics, epigenomics and transcriptomics in pancreatic cancer.
In: Epigenomics, Bd. 12, Nr. 6: S. 507-524
Kong, Lingming; Liu, Peng; Zheng, Mingjun; Wang, Zhongpeng; Gao, Yang; Liang, Keke; Wang, Huaitao und Tan, Xiaodong
(2020):
The miR-1224-5p/ELF3 Axis Regulates Malignant Behaviors of Pancreatic Cancer via PI3K/AKT/Notch Signaling Pathways.
In: Oncotargets and Therapy, Bd. 13: S. 3449-3466
[PDF, 17MB]
Zou, Ruoyao; Zheng, Mingjun; Tan, Mingzi; Xu, Haoya; Luan, Nannan und Zhu, Liancheng
(2020):
Decreased PTGDS Expression Predicting Poor Survival of Endometrial Cancer by Integrating Weighted Gene Co-Expression Network Analysis and Immunohistochemical Validation.
In: Cancer Management and Research, Bd. 12: S. 5057-5075
Zheng, Mingjun; Hu, Yuexin; Gou, Rui; Liu, Ouxuan; Nie, Xin; Li, Xiao; Liu, Qing; Hao, Yingying; Liu, Juanjuan und Lin, Bei
(2020):
Identification of immune-enhanced molecular subtype associated with BRCA1 mutations, immune checkpoints and clinical outcome in ovarian carcinoma.
In: Journal of Cellular and Molecular Medicine, Bd. 24, Nr. 5: S. 2819-2831
Zheng, Mingjun; Hu, Yuexin; Gou, Rui; Nie, Xin; Li, Xiao; Liu, Juanjuan und Lin, Bei
(2020):
Identification three LncRNA prognostic signature of ovarian cancer based on genome-wide copy number variation.
In: Biomedicine & Pharmacotherapy, Bd. 124, 109810